ES2969080T3 - Procedimiento de fabricación de n-acetil-taurinato de magnesio - Google Patents

Procedimiento de fabricación de n-acetil-taurinato de magnesio Download PDF

Info

Publication number
ES2969080T3
ES2969080T3 ES20179342T ES20179342T ES2969080T3 ES 2969080 T3 ES2969080 T3 ES 2969080T3 ES 20179342 T ES20179342 T ES 20179342T ES 20179342 T ES20179342 T ES 20179342T ES 2969080 T3 ES2969080 T3 ES 2969080T3
Authority
ES
Spain
Prior art keywords
magnesium
precipitate
acetyl
taurinate
washing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES20179342T
Other languages
English (en)
Spanish (es)
Inventor
Philippe Danhier
Pascale Azzam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synapharm Industrial Synthesis SA
Original Assignee
Synapharm Industrial Synthesis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67060224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2969080(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synapharm Industrial Synthesis SA filed Critical Synapharm Industrial Synthesis SA
Application granted granted Critical
Publication of ES2969080T3 publication Critical patent/ES2969080T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/06—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42—Separation; Purification; Stabilisation; Use of additives
    • C07C303/44—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
    • C07C317/04—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
ES20179342T 2019-06-11 2020-06-10 Procedimiento de fabricación de n-acetil-taurinato de magnesio Active ES2969080T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE20195372A BE1026955B1 (fr) 2019-06-11 2019-06-11 Procédé de fabrication de N-acétyl-taurinate de magnésium

Publications (1)

Publication Number Publication Date
ES2969080T3 true ES2969080T3 (es) 2024-05-16

Family

ID=67060224

Family Applications (1)

Application Number Title Priority Date Filing Date
ES20179342T Active ES2969080T3 (es) 2019-06-11 2020-06-10 Procedimiento de fabricación de n-acetil-taurinato de magnesio

Country Status (13)

Country Link
US (1) US11053194B2 (pl)
EP (1) EP3750873B1 (pl)
CN (1) CN112062696B (pl)
BE (1) BE1026955B1 (pl)
BR (1) BR102020011608A2 (pl)
CA (1) CA3082669A1 (pl)
DK (1) DK3750873T3 (pl)
ES (1) ES2969080T3 (pl)
FI (1) FI3750873T3 (pl)
MX (1) MX2020006070A (pl)
PL (1) PL3750873T3 (pl)
PT (1) PT3750873T (pl)
SI (1) SI3750873T1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112047862A (zh) * 2020-09-16 2020-12-08 浙江天瑞化学有限公司 一种乙酰牛磺酸镁的制备方法及其设备
WO2026013679A1 (en) * 2024-07-11 2026-01-15 Celagenex Research (India) Pvt. Ltd. A conjugate compound for regulation of mbp expression and novel in-situ process for preparation thereof.
CN119504517B (zh) * 2025-01-22 2025-04-18 浙江天启生化股份有限公司 一种乙酰牛磺酸镁的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2384751A1 (fr) * 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
US5582839A (en) * 1995-04-18 1996-12-10 Nutrition 21 Magnesium taurate and other mineral taurates
CN1887862A (zh) * 2006-07-19 2007-01-03 江阴南极星生物制品有限公司 牛磺酸镁的合成方法
FR2927809B1 (fr) * 2008-02-26 2011-01-14 Tri Inov Nouvelle utilisation de n-acetyl-taurinate de zinc.
JP2016520653A (ja) * 2013-06-05 2016-07-14 シンクロニューロン インコーポレイテッド アカンプロサート製剤、それを用いる方法、およびそれを含む合剤
CN107197511B (zh) * 2017-07-07 2020-04-14 京信通信系统（中国）有限公司 一种功率调整方法和系统
BE1026496B1 (fr) * 2019-05-16 2020-02-19 Synapharm Ind Synthesis Composé et composition pour utilisation dans le traitement du syndrome prémenstruel et/ou du trouble dysphorique prémenstruel

Also Published As

Publication number Publication date
US11053194B2 (en) 2021-07-06
BE1026955B1 (fr) 2020-08-04
FI3750873T3 (fi) 2024-01-15
PT3750873T (pt) 2024-01-08
BR102020011608A2 (pt) 2020-12-15
EP3750873B1 (fr) 2023-12-20
PL3750873T3 (pl) 2024-03-25
EP3750873A1 (fr) 2020-12-16
DK3750873T3 (da) 2024-01-15
SI3750873T1 (sl) 2024-03-29
CA3082669A1 (en) 2020-12-11
CN112062696A (zh) 2020-12-11
US20200392078A1 (en) 2020-12-17
MX2020006070A (es) 2022-12-06
CN112062696B (zh) 2023-07-28

Similar Documents

Publication Publication Date Title
EA201492126A1 (ru) Фармацевтические композиции, содержащие рифаксимин и аминокислоты, способ их получения и их применение
Wang et al. Esterase-sensitive sulfur dioxide prodrugs inspired by modified Julia olefination
BRPI0506976B8 (pt) processos para o preparo de um isolado de proteína de canola.
RU2002127470A (ru) Стабилизирующий состав
US11053194B2 (en) Production process for magnesium N-acetyl taurinate
EA202192753A1 (ru) Повышенная эффективность аморфных твердых и солюбилизированных составов для достижения терапевтических концентраций в плазме
CN104525044B (zh) Gemini季铵盐类阳离子表面活性剂及其合成方法
BR112014029841B1 (pt) processo para a preparação de um complexo de sulforafano e ciclodextrina, complexo de sulforafano-ciclodextrina, e, composição farmacêutica
ES2791295T3 (es) Procedimiento para purificar ácido ferúlico y/o sales del mismo
JP4967659B2 (ja) Ｌ−カルニチンの精製方法
FR3079140B1 (fr) Composition prebiotique
Dong et al. Eleven supramolecular adducts of 5, 7-dimethyl-1, 8-naphthyridine-2-amine and organic acids assembled by classical hydrogen bonds and other noncovalent intermolecular interactions
CN107955190A (zh) 离子液体和使用该离子液体溶解纤维素的方法
CN102086239A (zh) 抗凝血蚕蛹壳聚糖衍生物的制备方法
CN103949185B (zh) 一种具备杀菌活性的阴离子表面活性剂及其制备方法
HK40040565B (zh) N-乙酰牛磺酸镁的生产方法
JPS58203982A (ja) ビタミンｅ−アミノ酸エステル類およびその製造方法
AR127964A1 (es) Sal novedosa de un derivado de 1-sulfonilpirrol, método de preparación de la misma y composición farmacéutica que comprende la misma
CL2021002313A1 (es) Composición de la inulina y procedimiento de purificación de la inulina.
EP1868613A4 (en) POLYMORPHOS OF 3-O- (3 ', 3'-DIMETHYLSUCCINYL) BETULINIC DI-N-METHYL-D-GLUCAMINE
BR112014000490A2 (pt) feixe de fibras
AR067610A1 (es) Procedimiento para aumentar la resistencia de las plantas a un estres abiotico
RU2009114805A (ru) Средство, обладающее гепатозащитным и противовоспалительным действием, и способ его получения
ES2261508T3 (es) Procedimiento para la produccion de sal de disodio del acido fenilen-bis-bencimidazol-tetrasulfonico.
Stupnišek et al. BPC157 and its effects on hemostatic parameters in rats treated with warfarin, L-NAME and L-arginine